Microneedle Drug Delivery Systems Market
Microneedle Drug Delivery Systems Market by Product, End-user & Region | Forecast 2023 to 2033
According to FMI Research, One of the Key Factors Driving the Market's Growth is the Rising Global Population of Obese People.
Microneedle Drug Delivery Systems Market Outlook (2023 to 2033)
As per the latest market research conducted by FMI, the global microneedle drug delivery systems market is expected to record a CAGR of 6.6% from 2023 to 2033. In 2023, the market size is projected to reach a valuation of US$ 768.9 million. By 2033, the valuation is anticipated to reach US$ 1459.1 million.
In order to administer enough doses of medication to have the desired therapeutic effect, hundreds of microneedles are arranged in arrays on a small patch. As a result, there is now a direct route for a medication to enter the viable epidermis without coming into contact with the nerves and blood vessels found in the dermal layers. Depending on their qualities, numerous types of materials, including ceramic, silicon, silica glass, carbohydrates, and polymers, are utilized to make microneedles, thus driving the microneedling tool market in the coming years. Typically, microneedles measure hundreds of microns in length, 1 to 50 micrometers in width at the tip, and 50 to 300 micrometers in length at the base.
Significant Market Trends:
- The significant element promoting the growth of the market is the increased focus on improving the state of healthcare facilities, microneedling treatment, and the infrastructure for healthcare as a whole. Which on the other hand is expected to drive the growth of the microneedling treatment market.
- Increased public-private partnerships and strategic partnerships for the purpose of funding and implementing new and improved technology are also opening up lucrative market prospects for the plasma microneedling market as well.
- One of the key factors driving the market's growth is the rising global population of overweight and obese people.
- The countries with the greatest obesity rates are India, Germany, China, the United States, and the United Kingdom. Many health issues in the body are caused by obesity. Diabetes, respiratory issues, and other acute and chronic illnesses are a few examples.
- Likewise, an increase in public-private funding for targeted research initiatives, growing awareness of the harmful effects of obesity on the body, an increase in the prevalence of chronic and acute illnesses, a rise in the global geriatric population, and an increase in product innovations and development as a result of technological advancements which is expected to create lucrative opportunities for market participants during the forecast period.
- Increasing investment in research & development, particularly in developed and developing nations, is likely to open up lucrative market expansion opportunities for medical instruments and technologies. The market growth rate is also being boosted by research and development efforts to produce the finest possible treatments to combat obesity.
- In the future, the market's growth rate is likely to be increased by the availability of safer alternatives to traditional hypodermic injection, increasing demand for less invasive drug delivery systems, growing internet penetration rate, increase in cardiovascular disease cases, and rising per capita spending on health care.
| Attributes | Value |
|---|---|
| Microneedle Drug Delivery Systems Value (2022) | US$ 722.2 million |
| Microneedle Drug Delivery Systems Market Expected Value (2023) | US$ 768.9 million |
| Microneedle Drug Delivery Systems Market Forecast Value (2033) | US$ 1459.1 million |
| Microneedle Drug Delivery Systems Market Expected CAGR (2023 to 2033) | 6.6% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Restraining Factors of the Microneedle Drug Delivery Systems Market
- Nevertheless, constraints to market expansion are anticipated to include high costs associated with research and development capabilities, a lack of adequate infrastructure, unequal access to medical services, growing interest in alternative drug delivery methods like transdermal and intradermal systems, and a lack of awareness in developing nations.
- Besides, it is anticipated that the absence of a favorable reimbursement scenario, a lack of technology penetration in developing economies, poor absorption and variation in absorption, a lack of adequate infrastructure in low- and middle-income groups, limited insurance coverage, and a lack of regulatory compliance is anticipated to pose challenges to the market during the forecast period.
Comparative Analysis of Adjacent Markets
Microneedle Drug Delivery Systems Market:
| Differentiating Aspects | Microneedle Drug Delivery Systems Market |
|---|---|
| Anticipated CAGR (2023 to 2033) | 6.6% |
| Market Valuation (2023) | US$ 768.9 million |
| Growth Factors | The rising population of obese people. |
| Future Opportunities | The increased focus on improving the state of healthcare facilities and the infrastructure for healthcare as a whole. |
| Market Trends | Increased public-private partnerships and strategic partnerships. |
Respiratory Pathogen Testing Kits Market:
| Differentiating Aspects | Respiratory Pathogen Testing Kits Market |
|---|---|
| Anticipated CAGR (2023 to 2033) | 5.7% |
| Market Valuation (2023) | US$ 4083.1 million |
| Growth Factors | Rising chronic illness prevalence and increasing pathogen testing and preventative healthcare awareness. |
| Future Opportunities | The market for respiratory pathogen testing kits is driven by a significant increase in respiratory illness incidences. |
| Market Trends | Future market demand is likely to be profitable since developing and emerging economies have access to improved healthcare facilities. |
Blood Transfusion Market:
| Differentiating Aspects | Blood Transfusion Market |
|---|---|
| Anticipated CAGR (2023 to 2033) | 7% |
| Market Valuation (2023) | US$ 4.69 billion |
| Growth Factors | Blood transfusion demand is predicted to rise due to an increase in anemic people who require red blood cell transfusions to treat their condition. |
| Future Opportunities | The use of stem cell technologies to manufacture lab-grown blood cells for human transfusion is one of the most advanced research procedures and is expected to create multiple opportunities. |
| Market Trends | The emergence of cost-effective and novel technology to inactivate or minimize the risk of infection is increasing demand for a pathogen reduction system. |
Sabyasachi Ghosh
Principal Consultant
Talk to Analyst
Find your sweet spots for generating winning opportunities in this market.
Primary Market Trends
- The emergence of safer substitutes for traditional hypodermic injections is the main factor behind the expansion of microneedle drug delivery systems.
- The popularity of safety concerns is another primary trend boosting the development of microneedle drug delivery systems.
- The launch of a new microneedle patch is expected to make it simpler to vaccinate people in the event of preventable diseases as percenters for disease control and prevention.
- Consequently, the need for microneedle drug delivery systems is increasing as a result of vaccines against numerous diseases like measles.
- Besides this, the microneedle patch can be given by medical professionals with little training.
- The most significant factor driving the market for microneedle drug delivery systems is the high adoption of emerging safety issues that have short- and long-term implications for clinicians, patients, health workers, and regulators, growing research and development measures, and increasing demands for a safer alternative to traditional hypodermic injections.
Developments in the Market
- According to the WHO, new instances of cancer are anticipated to increase by roughly 70% over the following 20 years, which may lead to a need for microneedle patches as a drug delivery method. The market for microneedle drug delivery systems is expected to be driven by advances in technology like microneedle patches and an increase in transdermal drug delivery applications for pain treatment, congestive heart failure, and hormone replacement. The market expansion for microneedle drug delivery systems is anticipated to be hampered by drug degradation, local discomfort, poor absorption, and variability in absorption.
- The Centers for Disease Control and Prevention claim that a new microneedle patch might make it simpler to immunize people against measles and other diseases that can be prevented by vaccination. Due to the highly contagious nature of the measles virus, measures should be taken throughout the production and administration of the vaccine. Every year, measles affects over 25 million people, and sadly, the global measles vaccination rate has been hovering around 85% for the past few years, which is below the target level.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
How The Market Progressed Till June 2022?
| Particulars | Details |
|---|---|
| H1, 2021 | 6.46% |
| H1, 2022 Projected | 6.60% |
| H1, 2022 Outlook | 6.10% |
| BPS Change - H1, 2022 (O) – H1, 2022 (P) | (-) 50 ↓ |
| BPS Change – H1, 2022 (O) – H1, 2021 | (-) 36 ↓ |
The comparative analysis and market growth rate of the global microneedle drug delivery systems market as studied by Future Market Insights shows a negative BPS growth in the H1-2022 outlook as compared to H1-2022 projected period by 50 BPS, and, a decline in the BPS growth is expected in H1-2022 over H1- 2021 duration with 36 basis point share (BPS).
The expensive costs of creating a reproducible microneedle patch as well as the high expenses of storing and packaging microneedles for safe distribution are also factors that have been cited as limiting the decline in BPS levels.
The market is expected to gain momentum towards expansion over the anticipated years thanks to the advantages of microneedles in advanced transdermal drug administration, including enhanced bioavailability of pharmaceuticals, reduced side effects, and rapid beginning of therapeutic action. The introduction of solid, dissolving, and coated microneedles for efficient transdermal drug administration is one of the market's major advances. With regard to medication safety and product licensing operations, the market for microneedle drug delivery systems is subject to changes based on regulatory and industry dynamics.
Country-wise Analysis
How is the United States Market for Microneedle Drug Delivery Systems Performing?
The Demand for Microneedles for Drug Delivery is Being Driven by an Increase in Cancer Patients
The demand for innovative and efficient drug delivery methods to enhance therapy is being driven by the rising prevalence of chronic diseases in the United States, including diabetes and cancer. As a result, businesses and research organizations are bringing new product development to the nation, establishing it as a profitable segment.
In 2022, the United States witnessed 1.9 million new cancer cases diagnosed and 609,360 cancer deaths, according to Cancer Facts & Figures (2022), an educational companion to Cancer Statistics (2022), an article published in the American Cancer Society journal. This is expected to encourage the development of new oncology treatments, driving the market for microneedle drug delivery systems in the country.
Why is the Demand for Microneedle Drug Delivery Systems in China Increasing so Rapidly?
Demand for High-Quality Drugs & Access to Low-Cost Raw Ingredients Allows China to Expand its Industry
China is anticipated to hold a significant position in the East Asia market over the projection period. China's government organizations are investing more money in developing the healthcare industry, which is fostering the production of novel pharmaceuticals therein.
Several international pharmaceutical companies are looking to expand their operations in China due to the abundance of low-cost raw materials and the increased demand for generic medicines.
Growth Outlook of Country-wise Insights:
| Countries | United States |
|---|---|
| CAGR (2018 to 2022) | 5.1% |
| CAGR (2023 to 2033) | 5.7% |
| Valuation (2033) | US$ 528.6 million |
| Countries | United Kingdom |
|---|---|
| CAGR (2018 to 2022) | 6.4% |
| CAGR (2023 to 2033) | 7.0% |
| Valuation (2033) | US$ 84.4 million |
| Countries | China |
|---|---|
| CAGR (2018 to 2022) | 5.7% |
| CAGR (2023 to 2033) | 6.2% |
| Valuation (2033) | US$ 77.1 million |
| Countries | Germany |
|---|---|
| CAGR (2018 to 2022) | 4.7% |
| CAGR (2023 to 2033) | 5.1% |
| Valuation (2033) | US$ 79.3 million |
Category-wise Analysis
Which Product Type Is Expected to Become Very Popular?
Solid Microneedles Dominate the Development of Microneedle Drug Delivery Devices
Solid microneedles remain the market leader despite a slight decline in market share during the anticipated time frame. They are anticipated to have covered more than 50% of the market by the end of 2033. In the meantime, hollow and dissolving microneedles are anticipated to proliferate more quickly with the usage of new technologies and uses.
Research on solid microneedles is now being conducted for several applications in an effort to increase their consistency, stability, and affordability. At the moment, research is concentrated on the creation of a microneedle array.
Which End User Segment is Predicted to Flourish in the Microneedle Drug Delivery Systems Market?
Hospitals Set to Account for Higher Consumption of Microneedles for Drug Delivery
In 2022, hospitals held a top position as end users, accounting for 44.1% of the global market. The expansion of the worldwide microneedle drug delivery systems market is anticipated to be aided by specialty clinics.
Specialty clinics held a 22% market share globally in 2022. As more clinics focus on particular disorders, the market potential is anticipated to rise in the future. For instance, one of the biggest consumers of microneedle drug delivery devices for procedures like hair restoration, facelifts, and wrinkle therapy are cosmetic clinics. Which is expected to eventually drive the microneedling for hair loss market.
Competitive Background
The global microneedle drug delivery systems market is dominated by large- and medium-sized companies. However, it is led by a few important companies that, as part of their marketing strategy, are focusing on their market and value chain positions. Prominent market players use a range of tactics, such as early market entry, deep market penetration, as well as exclusive marketing and distribution licensing. Product innovation and differentiation, however, are essential market strategies for both mid-size and large businesses due to the diversity of market players.
Regardless of their size, companies use distribution rights acquisition and exclusive technology licensing as core strategies. In particular, a few businesses are focusing on strategic alliances in order to get a competitive edge.
Leading companies that sell microneedle drug delivery equipment are concentrating on Research and Development to introduce cutting-edge items in the market. In order to obtain a competitive edge in the market, firms are also engaging in mergers, acquisitions, and collaborations.
Significant Market Players Include
- 3M Company
- Becton
- Dickinson and Company
- Zosano Pharma Corporation
- Raphas Co. Ltd.
- Nanopass Tech
- Corium International Inc.
- Valeritas Inc.
- Nitto Denko Corporation
- Microdermics Inc.
- TheraJect Inc.
- Vaxxas Pty Ltd.
- Endoderma Ltd.
- QuadMedicine
- SNvia Co. Ltd.
- Small Lab
- AdminMed nanoBioSciences LLC
Microneedle Drug Delivery Systems Industry Report Scope
| Attribute | Details |
|---|---|
| Forecast Period | 2023 to 2033 |
| Historical Data Available for | 2018 to 2022 |
| Market Analysis | US$ million for Value |
| Key Regions Covered |
|
| Key Countries Covered |
|
| Key Market Segments Covered |
|
| Key Companies Profiled |
|
| Pricing | Available upon Request |
Key Segments of Microneedle Drug Delivery Systems Industry Survey
Microneedle Drug Delivery Systems Market by Product:
- Solid Microneedles
- Silicon
- Metal
- Polymer
- Hollow Microneedles
- Dissolving Microneedles
Microneedle Drug Delivery Systems Market by End User:
- Hospitals
- Ambulatory Surgical Centers
- Specialty Clinics
- Academic Institutions
- Research Institutes
Microneedle Drug Delivery Systems Market by Region:
- North America Microneedle Drug Delivery Systems Market
- Latin America Microneedle Drug Delivery Systems Market
- Europe Microneedle Drug Delivery Systems Market
- East Asia Microneedle Drug Delivery Systems Market
- South Asia & Pacific Microneedle Drug Delivery Systems Market
- Middle East & Africa (MEA) Microneedle Drug Delivery Systems Market
Frequently Asked Questions
What is the Revenue Generating Capacity of the Global Microneedle Drug Delivery Systems Market?
The market may register a revenue of US$ 768.9 million in 2023.
Which Country is Leading in the Microneedle Drug Delivery Systems Market?
The United States is the leading country in the market.
Which Asian Country is Dominating the Market?
China is the leading market and is expected to grow at 6.2% until 2033.
Based on Product Type, Which Segment Dominates the Market?
The solid microneedle segment dominates and could hold 50% of the global market by 2033.
Which is the Leading End-user Type in the Market?
The hospitals segment accounted the top position with 44.1% market share in 2022.
Table of Content
1. Executive Summary | Microneedle Drug Delivery Systems Market 1.1. Global Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Technology Roadmap Analysis 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Opportunity Map Analysis 3.4. Investment Feasibility Matrix 3.5. PESTLE and Porter’s Analysis 3.6. Regulatory Landscape 3.6.1. By Key Regions 3.6.2. By Key Countries 3.7. Regional Parent Market Outlook 4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033 4.1. Historical Market Size Value (US$ Million) Analysis, 2018 to 2022 4.2. Current and Future Market Size Value (US$ Million) Projections, 2023 to 2033 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Product 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ Million) Analysis By Product, 2018 to 2022 5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Product, 2023 to 2033 5.3.1. Solid Microneedles 5.3.1.1. Silicon 5.3.1.2. Metal 5.3.1.3. Polymer 5.3.2. Hollow Microneedles 5.3.3. Dissolving Microneedles 5.4. Y-o-Y Growth Trend Analysis By Product, 2018 to 2022 5.5. Absolute $ Opportunity Analysis By Product, 2023 to 2033 6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End Use 6.1. Introduction / Key Findings 6.2. Historical Market Size Value (US$ Million) Analysis By End Use, 2018 to 2022 6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End Use, 2023 to 2033 6.3.1. Hospitals 6.3.2. Ambulatory Surgical Centers 6.3.3. Specialty Clinics 6.3.4. Academic Institutions 6.3.5. Research Institutes 6.4. Y-o-Y Growth Trend Analysis By End Use, 2018 to 2022 6.5. Absolute $ Opportunity Analysis By End Use, 2023 to 2033 7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region 7.1. Introduction 7.2. Historical Market Size Value (US$ Million) Analysis By Region, 2018 to 2022 7.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023 to 2033 7.3.1. North America 7.3.2. Latin America 7.3.3. Europe 7.3.4. South Asia 7.3.5. East Asia 7.3.6. Oceania 7.3.7. Middle East and Africa 7.4. Market Attractiveness Analysis By Region 8. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 8.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 8.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 8.2.1. By Country 8.2.1.1. USA 8.2.1.2. Canada 8.2.2. By Product 8.2.3. By End Use 8.3. Market Attractiveness Analysis 8.3.1. By Country 8.3.2. By Product 8.3.3. By End Use 8.4. Key Takeaways 9. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 9.2.1. By Country 9.2.1.1. Brazil 9.2.1.2. Mexico 9.2.1.3. Rest of Latin America 9.2.2. By Product 9.2.3. By End Use 9.3. Market Attractiveness Analysis 9.3.1. By Country 9.3.2. By Product 9.3.3. By End Use 9.4. Key Takeaways 10. Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 10.2.1. By Country 10.2.1.1. United Kingdom 10.2.1.2. Spain 10.2.1.3. Germany 10.2.1.4. Italy 10.2.1.5. France 10.2.1.6. Rest of Europe 10.2.2. By Product 10.2.3. By End Use 10.3. Market Attractiveness Analysis 10.3.1. By Country 10.3.2. By Product 10.3.3. By End Use 10.4. Key Takeaways 11. South Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 11.2.1. By Country 11.2.1.1. India 11.2.1.2. Malaysia 11.2.1.3. Indonesia 11.2.1.4. Thailand 11.2.1.5. Rest of South Asia 11.2.2. By Product 11.2.3. By End Use 11.3. Market Attractiveness Analysis 11.3.1. By Country 11.3.2. By Product 11.3.3. By End Use 11.4. Key Takeaways 12. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 12.2.1. By Country 12.2.1.1. China 12.2.1.2. Japan 12.2.1.3. South Korea 12.2.2. By Product 12.2.3. By End Use 12.3. Market Attractiveness Analysis 12.3.1. By Country 12.3.2. By Product 12.3.3. By End Use 12.4. Key Takeaways 13. Oceania Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 13.2.1. By Country 13.2.1.1. Australia 13.2.1.2. New Zealand 13.2.2. By Product 13.2.3. By End Use 13.3. Market Attractiveness Analysis 13.3.1. By Country 13.3.2. By Product 13.3.3. By End Use 13.4. Key Takeaways 14. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 14.2.1. By Country 14.2.1.1. South Africa 14.2.1.2. GCC Countries 14.2.1.3. Rest of Middle East and Africa 14.2.2. By Product 14.2.3. By End Use 14.3. Market Attractiveness Analysis 14.3.1. By Country 14.3.2. By Product 14.3.3. By End Use 14.4. Key Takeaways 15. Key Countries Market Analysis 15.1. USA 15.1.1. Pricing Analysis 15.1.2. Market Share Analysis, 2022 15.1.2.1. By Product 15.1.2.2. By End Use 15.2. Canada 15.2.1. Pricing Analysis 15.2.2. Market Share Analysis, 2022 15.2.2.1. By Product 15.2.2.2. By End Use 15.3. Brazil 15.3.1. Pricing Analysis 15.3.2. Market Share Analysis, 2022 15.3.2.1. By Product 15.3.2.2. By End Use 15.4. Mexico 15.4.1. Pricing Analysis 15.4.2. Market Share Analysis, 2022 15.4.2.1. By Product 15.4.2.2. By End Use 15.5. United Kingdom 15.5.1. Pricing Analysis 15.5.2. Market Share Analysis, 2022 15.5.2.1. By Product 15.5.2.2. By End Use 15.6. Spain 15.6.1. Pricing Analysis 15.6.2. Market Share Analysis, 2022 15.6.2.1. By Product 15.6.2.2. By End Use 15.7. Germany 15.7.1. Pricing Analysis 15.7.2. Market Share Analysis, 2022 15.7.2.1. By Product 15.7.2.2. By End Use 15.8. Italy 15.8.1. Pricing Analysis 15.8.2. Market Share Analysis, 2022 15.8.2.1. By Product 15.8.2.2. By End Use 15.9. France 15.9.1. Pricing Analysis 15.9.2. Market Share Analysis, 2022 15.9.2.1. By Product 15.9.2.2. By End Use 15.10. India 15.10.1. Pricing Analysis 15.10.2. Market Share Analysis, 2022 15.10.2.1. By Product 15.10.2.2. By End Use 15.11. Malaysia 15.11.1. Pricing Analysis 15.11.2. Market Share Analysis, 2022 15.11.2.1. By Product 15.11.2.2. By End Use 15.12. Indonesia 15.12.1. Pricing Analysis 15.12.2. Market Share Analysis, 2022 15.12.2.1. By Product 15.12.2.2. By End Use 15.13. Thailand 15.13.1. Pricing Analysis 15.13.2. Market Share Analysis, 2022 15.13.2.1. By Product 15.13.2.2. By End Use 15.14. China 15.14.1. Pricing Analysis 15.14.2. Market Share Analysis, 2022 15.14.2.1. By Product 15.14.2.2. By End Use 15.15. Japan 15.15.1. Pricing Analysis 15.15.2. Market Share Analysis, 2022 15.15.2.1. By Product 15.15.2.2. By End Use 15.16. South Korea 15.16.1. Pricing Analysis 15.16.2. Market Share Analysis, 2022 15.16.2.1. By Product 15.16.2.2. By End Use 15.17. Australia 15.17.1. Pricing Analysis 15.17.2. Market Share Analysis, 2022 15.17.2.1. By Product 15.17.2.2. By End Use 15.18. New Zealand 15.18.1. Pricing Analysis 15.18.2. Market Share Analysis, 2022 15.18.2.1. By Product 15.18.2.2. By End Use 15.19. South Africa 15.19.1. Pricing Analysis 15.19.2. Market Share Analysis, 2022 15.19.2.1. By Product 15.19.2.2. By End Use 15.20. GCC Countries 15.20.1. Pricing Analysis 15.20.2. Market Share Analysis, 2022 15.20.2.1. By Product 15.20.2.2. By End Use 16. Market Structure Analysis 16.1. Competition Dashboard 16.2. Competition Benchmarking 16.3. Market Share Analysis of Top Players 16.3.1. By Regional 16.3.2. By Product 16.3.3. By End Use 17. Competition Analysis 17.1. Competition Deep Dive 17.1.1. 3M Company 17.1.1.1. Overview 17.1.1.2. Product Portfolio 17.1.1.3. Profitability by Market Segments 17.1.1.4. Sales Footprint 17.1.1.5. Strategy Overview 17.1.1.5.1. Marketing Strategy 17.1.2. Becton, Dickinson and Company 17.1.2.1. Overview 17.1.2.2. Product Portfolio 17.1.2.3. Profitability by Market Segments 17.1.2.4. Sales Footprint 17.1.2.5. Strategy Overview 17.1.2.5.1. Marketing Strategy 17.1.3. Zosano Pharma Corporation 17.1.3.1. Overview 17.1.3.2. Product Portfolio 17.1.3.3. Profitability by Market Segments 17.1.3.4. Sales Footprint 17.1.3.5. Strategy Overview 17.1.3.5.1. Marketing Strategy 17.1.4. RAPHAS Co., Ltd. 17.1.4.1. Overview 17.1.4.2. Product Portfolio 17.1.4.3. Profitability by Market Segments 17.1.4.4. Sales Footprint 17.1.4.5. Strategy Overview 17.1.4.5.1. Marketing Strategy 17.1.5. Nanopass Tech 17.1.5.1. Overview 17.1.5.2. Product Portfolio 17.1.5.3. Profitability by Market Segments 17.1.5.4. Sales Footprint 17.1.5.5. Strategy Overview 17.1.5.5.1. Marketing Strategy 17.1.6. Corium International, Inc. 17.1.6.1. Overview 17.1.6.2. Product Portfolio 17.1.6.3. Profitability by Market Segments 17.1.6.4. Sales Footprint 17.1.6.5. Strategy Overview 17.1.6.5.1. Marketing Strategy 17.1.7. Valeritas, Inc. 17.1.7.1. Overview 17.1.7.2. Product Portfolio 17.1.7.3. Profitability by Market Segments 17.1.7.4. Sales Footprint 17.1.7.5. Strategy Overview 17.1.7.5.1. Marketing Strategy 17.1.8. Nitto Denko Corporation 17.1.8.1. Overview 17.1.8.2. Product Portfolio 17.1.8.3. Profitability by Market Segments 17.1.8.4. Sales Footprint 17.1.8.5. Strategy Overview 17.1.8.5.1. Marketing Strategy 17.1.9. Microdermics, Inc. 17.1.9.1. Overview 17.1.9.2. Product Portfolio 17.1.9.3. Profitability by Market Segments 17.1.9.4. Sales Footprint 17.1.9.5. Strategy Overview 17.1.9.5.1. Marketing Strategy 17.1.10. TheraJect Inc. 17.1.10.1. Overview 17.1.10.2. Product Portfolio 17.1.10.3. Profitability by Market Segments 17.1.10.4. Sales Footprint 17.1.10.5. Strategy Overview 17.1.10.5.1. Marketing Strategy 17.1.11. Vaxxas Pty Ltd. 17.1.11.1. Overview 17.1.11.2. Product Portfolio 17.1.11.3. Profitability by Market Segments 17.1.11.4. Sales Footprint 17.1.11.5. Strategy Overview 17.1.11.5.1. Marketing Strategy 17.1.12. Endoderma Ltd. 17.1.12.1. Overview 17.1.12.2. Product Portfolio 17.1.12.3. Profitability by Market Segments 17.1.12.4. Sales Footprint 17.1.12.5. Strategy Overview 17.1.12.5.1. Marketing Strategy 17.1.13. QuadMedicine 17.1.13.1. Overview 17.1.13.2. Product Portfolio 17.1.13.3. Profitability by Market Segments 17.1.13.4. Sales Footprint 17.1.13.5. Strategy Overview 17.1.13.5.1. Marketing Strategy 17.1.14. SNvia Co., Ltd. 17.1.14.1. Overview 17.1.14.2. Product Portfolio 17.1.14.3. Profitability by Market Segments 17.1.14.4. Sales Footprint 17.1.14.5. Strategy Overview 17.1.14.5.1. Marketing Strategy 18. Assumptions & Acronyms Used 19. Research Methodology
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
List of Tables
Table 1: Global Market Value (US$ Million) Forecast by Region, 2018 to 2033 Table 2: Global Market Value (US$ Million) Forecast by Product, 2018 to 2033 Table 3: Global Market Value (US$ Million) Forecast by End Use, 2018 to 2033 Table 4: North America Market Value (US$ Million) Forecast by Country, 2018 to 2033 Table 5: North America Market Value (US$ Million) Forecast by Product, 2018 to 2033 Table 6: North America Market Value (US$ Million) Forecast by End Use, 2018 to 2033 Table 7: Latin America Market Value (US$ Million) Forecast by Country, 2018 to 2033 Table 8: Latin America Market Value (US$ Million) Forecast by Product, 2018 to 2033 Table 9: Latin America Market Value (US$ Million) Forecast by End Use, 2018 to 2033 Table 10: Europe Market Value (US$ Million) Forecast by Country, 2018 to 2033 Table 11: Europe Market Value (US$ Million) Forecast by Product, 2018 to 2033 Table 12: Europe Market Value (US$ Million) Forecast by End Use, 2018 to 2033 Table 13: South Asia Market Value (US$ Million) Forecast by Country, 2018 to 2033 Table 14: South Asia Market Value (US$ Million) Forecast by Product, 2018 to 2033 Table 15: South Asia Market Value (US$ Million) Forecast by End Use, 2018 to 2033 Table 16: East Asia Market Value (US$ Million) Forecast by Country, 2018 to 2033 Table 17: East Asia Market Value (US$ Million) Forecast by Product, 2018 to 2033 Table 18: East Asia Market Value (US$ Million) Forecast by End Use, 2018 to 2033 Table 19: Oceania Market Value (US$ Million) Forecast by Country, 2018 to 2033 Table 20: Oceania Market Value (US$ Million) Forecast by Product, 2018 to 2033 Table 21: Oceania Market Value (US$ Million) Forecast by End Use, 2018 to 2033 Table 22: Middle East and Africa Market Value (US$ Million) Forecast by Country, 2018 to 2033 Table 23: Middle East and Africa Market Value (US$ Million) Forecast by Product, 2018 to 2033 Table 24: Middle East and Africa Market Value (US$ Million) Forecast by End Use, 2018 to 2033
Sabyasachi Ghosh
Principal Consultant
Talk to Analyst
Find your sweet spots for generating winning opportunities in this market.
List of Charts
Figure 1: Global Market Value (US$ Million) by Product, 2023 to 2033 Figure 2: Global Market Value (US$ Million) by End Use, 2023 to 2033 Figure 3: Global Market Value (US$ Million) by Region, 2023 to 2033 Figure 4: Global Market Value (US$ Million) Analysis by Region, 2018 to 2033 Figure 5: Global Market Value Share (%) and BPS Analysis by Region, 2023 to 2033 Figure 6: Global Market Y-o-Y Growth (%) Projections by Region, 2023 to 2033 Figure 7: Global Market Value (US$ Million) Analysis by Product, 2018 to 2033 Figure 8: Global Market Value Share (%) and BPS Analysis by Product, 2023 to 2033 Figure 9: Global Market Y-o-Y Growth (%) Projections by Product, 2023 to 2033 Figure 10: Global Market Value (US$ Million) Analysis by End Use, 2018 to 2033 Figure 11: Global Market Value Share (%) and BPS Analysis by End Use, 2023 to 2033 Figure 12: Global Market Y-o-Y Growth (%) Projections by End Use, 2023 to 2033 Figure 13: Global Market Attractiveness by Product, 2023 to 2033 Figure 14: Global Market Attractiveness by End Use, 2023 to 2033 Figure 15: Global Market Attractiveness by Region, 2023 to 2033 Figure 16: North America Market Value (US$ Million) by Product, 2023 to 2033 Figure 17: North America Market Value (US$ Million) by End Use, 2023 to 2033 Figure 18: North America Market Value (US$ Million) by Country, 2023 to 2033 Figure 19: North America Market Value (US$ Million) Analysis by Country, 2018 to 2033 Figure 20: North America Market Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 21: North America Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 22: North America Market Value (US$ Million) Analysis by Product, 2018 to 2033 Figure 23: North America Market Value Share (%) and BPS Analysis by Product, 2023 to 2033 Figure 24: North America Market Y-o-Y Growth (%) Projections by Product, 2023 to 2033 Figure 25: North America Market Value (US$ Million) Analysis by End Use, 2018 to 2033 Figure 26: North America Market Value Share (%) and BPS Analysis by End Use, 2023 to 2033 Figure 27: North America Market Y-o-Y Growth (%) Projections by End Use, 2023 to 2033 Figure 28: North America Market Attractiveness by Product, 2023 to 2033 Figure 29: North America Market Attractiveness by End Use, 2023 to 2033 Figure 30: North America Market Attractiveness by Country, 2023 to 2033 Figure 31: Latin America Market Value (US$ Million) by Product, 2023 to 2033 Figure 32: Latin America Market Value (US$ Million) by End Use, 2023 to 2033 Figure 33: Latin America Market Value (US$ Million) by Country, 2023 to 2033 Figure 34: Latin America Market Value (US$ Million) Analysis by Country, 2018 to 2033 Figure 35: Latin America Market Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 36: Latin America Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 37: Latin America Market Value (US$ Million) Analysis by Product, 2018 to 2033 Figure 38: Latin America Market Value Share (%) and BPS Analysis by Product, 2023 to 2033 Figure 39: Latin America Market Y-o-Y Growth (%) Projections by Product, 2023 to 2033 Figure 40: Latin America Market Value (US$ Million) Analysis by End Use, 2018 to 2033 Figure 41: Latin America Market Value Share (%) and BPS Analysis by End Use, 2023 to 2033 Figure 42: Latin America Market Y-o-Y Growth (%) Projections by End Use, 2023 to 2033 Figure 43: Latin America Market Attractiveness by Product, 2023 to 2033 Figure 44: Latin America Market Attractiveness by End Use, 2023 to 2033 Figure 45: Latin America Market Attractiveness by Country, 2023 to 2033 Figure 46: Europe Market Value (US$ Million) by Product, 2023 to 2033 Figure 47: Europe Market Value (US$ Million) by End Use, 2023 to 2033 Figure 48: Europe Market Value (US$ Million) by Country, 2023 to 2033 Figure 49: Europe Market Value (US$ Million) Analysis by Country, 2018 to 2033 Figure 50: Europe Market Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 51: Europe Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 52: Europe Market Value (US$ Million) Analysis by Product, 2018 to 2033 Figure 53: Europe Market Value Share (%) and BPS Analysis by Product, 2023 to 2033 Figure 54: Europe Market Y-o-Y Growth (%) Projections by Product, 2023 to 2033 Figure 55: Europe Market Value (US$ Million) Analysis by End Use, 2018 to 2033 Figure 56: Europe Market Value Share (%) and BPS Analysis by End Use, 2023 to 2033 Figure 57: Europe Market Y-o-Y Growth (%) Projections by End Use, 2023 to 2033 Figure 58: Europe Market Attractiveness by Product, 2023 to 2033 Figure 59: Europe Market Attractiveness by End Use, 2023 to 2033 Figure 60: Europe Market Attractiveness by Country, 2023 to 2033 Figure 61: South Asia Market Value (US$ Million) by Product, 2023 to 2033 Figure 62: South Asia Market Value (US$ Million) by End Use, 2023 to 2033 Figure 63: South Asia Market Value (US$ Million) by Country, 2023 to 2033 Figure 64: South Asia Market Value (US$ Million) Analysis by Country, 2018 to 2033 Figure 65: South Asia Market Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 66: South Asia Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 67: South Asia Market Value (US$ Million) Analysis by Product, 2018 to 2033 Figure 68: South Asia Market Value Share (%) and BPS Analysis by Product, 2023 to 2033 Figure 69: South Asia Market Y-o-Y Growth (%) Projections by Product, 2023 to 2033 Figure 70: South Asia Market Value (US$ Million) Analysis by End Use, 2018 to 2033 Figure 71: South Asia Market Value Share (%) and BPS Analysis by End Use, 2023 to 2033 Figure 72: South Asia Market Y-o-Y Growth (%) Projections by End Use, 2023 to 2033 Figure 73: South Asia Market Attractiveness by Product, 2023 to 2033 Figure 74: South Asia Market Attractiveness by End Use, 2023 to 2033 Figure 75: South Asia Market Attractiveness by Country, 2023 to 2033 Figure 76: East Asia Market Value (US$ Million) by Product, 2023 to 2033 Figure 77: East Asia Market Value (US$ Million) by End Use, 2023 to 2033 Figure 78: East Asia Market Value (US$ Million) by Country, 2023 to 2033 Figure 79: East Asia Market Value (US$ Million) Analysis by Country, 2018 to 2033 Figure 80: East Asia Market Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 81: East Asia Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 82: East Asia Market Value (US$ Million) Analysis by Product, 2018 to 2033 Figure 83: East Asia Market Value Share (%) and BPS Analysis by Product, 2023 to 2033 Figure 84: East Asia Market Y-o-Y Growth (%) Projections by Product, 2023 to 2033 Figure 85: East Asia Market Value (US$ Million) Analysis by End Use, 2018 to 2033 Figure 86: East Asia Market Value Share (%) and BPS Analysis by End Use, 2023 to 2033 Figure 87: East Asia Market Y-o-Y Growth (%) Projections by End Use, 2023 to 2033 Figure 88: East Asia Market Attractiveness by Product, 2023 to 2033 Figure 89: East Asia Market Attractiveness by End Use, 2023 to 2033 Figure 90: East Asia Market Attractiveness by Country, 2023 to 2033 Figure 91: Oceania Market Value (US$ Million) by Product, 2023 to 2033 Figure 92: Oceania Market Value (US$ Million) by End Use, 2023 to 2033 Figure 93: Oceania Market Value (US$ Million) by Country, 2023 to 2033 Figure 94: Oceania Market Value (US$ Million) Analysis by Country, 2018 to 2033 Figure 95: Oceania Market Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 96: Oceania Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 97: Oceania Market Value (US$ Million) Analysis by Product, 2018 to 2033 Figure 98: Oceania Market Value Share (%) and BPS Analysis by Product, 2023 to 2033 Figure 99: Oceania Market Y-o-Y Growth (%) Projections by Product, 2023 to 2033 Figure 100: Oceania Market Value (US$ Million) Analysis by End Use, 2018 to 2033 Figure 101: Oceania Market Value Share (%) and BPS Analysis by End Use, 2023 to 2033 Figure 102: Oceania Market Y-o-Y Growth (%) Projections by End Use, 2023 to 2033 Figure 103: Oceania Market Attractiveness by Product, 2023 to 2033 Figure 104: Oceania Market Attractiveness by End Use, 2023 to 2033 Figure 105: Oceania Market Attractiveness by Country, 2023 to 2033 Figure 106: Middle East and Africa Market Value (US$ Million) by Product, 2023 to 2033 Figure 107: Middle East and Africa Market Value (US$ Million) by End Use, 2023 to 2033 Figure 108: Middle East and Africa Market Value (US$ Million) by Country, 2023 to 2033 Figure 109: Middle East and Africa Market Value (US$ Million) Analysis by Country, 2018 to 2033 Figure 110: Middle East and Africa Market Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 111: Middle East and Africa Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 112: Middle East and Africa Market Value (US$ Million) Analysis by Product, 2018 to 2033 Figure 113: Middle East and Africa Market Value Share (%) and BPS Analysis by Product, 2023 to 2033 Figure 114: Middle East and Africa Market Y-o-Y Growth (%) Projections by Product, 2023 to 2033 Figure 115: Middle East and Africa Market Value (US$ Million) Analysis by End Use, 2018 to 2033 Figure 116: Middle East and Africa Market Value Share (%) and BPS Analysis by End Use, 2023 to 2033 Figure 117: Middle East and Africa Market Y-o-Y Growth (%) Projections by End Use, 2023 to 2033 Figure 118: Middle East and Africa Market Attractiveness by Product, 2023 to 2033 Figure 119: Middle East and Africa Market Attractiveness by End Use, 2023 to 2033 Figure 120: Middle East and Africa Market Attractiveness by Country, 2023 to 2033
Recommendations
Explore Healthcare Insights
View Reports
